MHLW Advisory Panel to Discuss Sanofi’s PCSK9 Inhibitor on May 27

May 16, 2016
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will discuss whether to recommend approval for Sanofi’s PCSK9 inhibitor alirocumab at its meeting on May 27. The Pharmaceutical Affairs and Food Sanitation Council’s First Committee on...read more